The pharmaceutical company with the highest revenue in the world, Johnson & Johnson (NYSE:JNJ) is considering a third bankruptcy filing right now after facing more than 50,000 lawsuits which have linked its Baby Powder to cancer. To add to its troubles, Johnson & Johnson (NYSE:JNJ) also recently missed out on its medical devices segment sales after which it decided to restructure its orthopedic business.